Loading...
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
BACKGROUND/AIMS: Several treatment options are currently available for patients with hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare the effectiveness of regorafenib and nivolumab in these patients. METHODS: Consecutive HCC patients who received regorafenib o...
Na minha lista:
| Udgivet i: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association for the Study of the Liver
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364358/ https://ncbi.nlm.nih.gov/pubmed/32460459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2019.0049n |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|